Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/05/2008CN100430359C Active compound bulbophyllum phenanthrene dimer A and its use
11/05/2008CN100430090C A composition for the prevention and/or treatment of atherosclerosis
11/05/2008CN100430078C Rare earth-containing medicinal ointment for treating scald and injury
11/05/2008CN100430073C Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug
11/05/2008CN100430070C Medication for treating coronary heart disease and angina
11/05/2008CN100430069C Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430066C Compounds for the treatment of tobacco dependence and withdrawal
11/05/2008CN100430065C Application of paris polyphyla var. yunnanensis stem and leaf monomer saponin in pharmaceutical industry
11/05/2008CN100430064C Use of scutellarin in inhibiting vascularization
11/05/2008CN100430063C Combination therapy wherein a serotonin reuptake inhibitor is used
11/05/2008CN100430062C Neuroprotective spirostenol pharmaceutical compositions
11/05/2008CN100430061C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
11/05/2008CN100430060C Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/05/2008CN100430058C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
11/05/2008CN100430057C Pharmaceutical compositions of levoamlodipine and atorvastatin
11/05/2008CN100430056C Use of MGLUR5 antagonists for the treatment of GERD
11/05/2008CN100430055C Glassiness sosoloid contg. 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazol formic-acid and polyvinyl pyrrolidone and its prepn. method
11/05/2008CN100430054C Use of green chiretta diterpene lactone in inhibiting vascularization
11/05/2008CN100430053C AIDS therapeutic drug and its uses
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/05/2008CN100430051C Pharmaceutical formulation comprising levothyroxine sodium
11/05/2008CN100430050C Use of rotigotine for the treatment of depression
11/05/2008CN100430049C Depressant of functions developed by molecule
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/05/2008CN100430046C Composition and method for treating age-related disorders
11/04/2008US7446229 side effects reduction; cannabimimetic compounds; high binding affinities via substituted alkyl side chains at the c-3 position for at least one cannabinoid receptor; agonists; (4R)-4-[4-(2-hexyl-1,3-dithiolan-2-yl)-2,6-dihydroxyphenyl]-6,6-dimethyl-2 beta -norpinanol; may contain terpene funtionality
11/04/2008US7446225 N-[5-methanesulfonyl-4-(4-methanesulfonyl-3-pentafluorosulfanylphenoxy)-2-methyl-benzoyl]guanidine; diagnostic agents for hypertension, diabetes, proliferative disorders; inhibitors of the cellular sodium-proton antiporter (Na/H exchanger); good absorption, bioavailability; angina pectoris, infarction
11/04/2008US7446219 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/04/2008US7446211 Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls
11/04/2008US7446209 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
11/04/2008US7446204 Amino substituted aryloxybenzylpiperidine derivatives
11/04/2008US7446201 Substituted heteroaryl benzofuran acids
11/04/2008US7446199 Compositions useful as inhibitors of protein kinases
11/04/2008US7446196 Leptomycin compounds
11/04/2008US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
11/04/2008US7446127 reduction of glucose, insulin, free fatty acids; treatment, control and prevention of diabetes, obesity, atherosclerosis, vascular inflammation and their related diseases; e.g. 7-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]chromane-3-carboxylic Acid
11/04/2008US7446126 Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
11/04/2008US7446125 Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders
11/04/2008US7446124 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
11/04/2008US7446123 Azabicyclo derivatives as muscarinic receptor antagonists
11/04/2008US7446122 Substituted indole derivatives
11/04/2008US7446121 Pyrazole-based HMG CoA reductase inhibitors
11/04/2008US7446120 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor
11/04/2008US7446118 depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; 5-(3-Methylamino-1H-phenyl-propyl)-1H-indole-3-carbonitrile
11/04/2008US7446117 Cox-2 inhibiting pyridine derivatives
11/04/2008US7446116 Montelukast amantadine salt
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
11/04/2008US7446112 Modulators of muscarinic receptors
11/04/2008US7446111 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions
11/04/2008US7446110 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; benign prostate hyperplasia, depression, sexual dysfuction, sleep apnea; ideal for hormone replacement therapy in hypogonadic men
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7446107 Soluble crystalline form of cis-itraconazole, posaconazole or saperconazole comprising the reaction product of cis-itraconazole, posaconazole or saperconazole and an organic acid or an inorganic acid; use in treating or preventing local and systemic fungal, yeast, and dermatophyte infections
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008US7446103 N-[4-(3-Piperidin-1-ylpropoxy)-benzoyl]-5-fluoroisoindoline; Alzheimer's disease; cognition enhancers; amidation
11/04/2008US7446101 Lutein/ gamma -cyclodextrin complex; improved absorption of lutein as compared to a commercially available free lutein-oil formulation
11/04/2008US7446100 Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
11/04/2008US7446098 combining gene therapy with active site-specific chaperones to increases the stability and efficiency of the protein encoded by the recombinant gene that is administered.
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
11/04/2008US7445931 Compositions and methods for enrichment of neural stem cells using ceramide analogs
11/04/2008US7445929 Recombinant adenovirus vector having a reduced side effect
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445891 Nucleic acid triggered catalytic drug and probe release
11/04/2008US7445803 Animal nutrient adjuvant; administering chromium complexed with methionine as animal nutritional supplements
11/04/2008US7445801 Stable bicarbonate-based solution in a single container
11/04/2008US7445794 Administering 2-deoxy-D-glucose and etomoxir and anti-Fas antibody for cancer therapy
11/04/2008US7445790 Contains an alkyl benzoate such as 3,7-dimethyloctyl benzoate (isodecyl benzoate); gives a refreshing sensation; sunblocks; superior long term emulsion stability
11/04/2008US7445771 1,3-bis[(dimethyl,hydroxymethyl) methylamino]propane; antiseptic and disinfectant; preventing microbial contamination; multi-functional component for contact lens solution and multi-dose ophthalmic compositions
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008US7445629 Medical device for delivering biologically active material
11/04/2008CA2578881C Vitamin d compositions and method of administration to a human being
11/04/2008CA2525550C Acridone-derived compounds useful as antiretroviral agents
11/04/2008CA2473760C Topical ivermectin composition
11/04/2008CA2457361C Opioid agonist formulations with releasable and sequestered antagonist
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2441860C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/04/2008CA2430470C Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
11/04/2008CA2400704C 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
11/04/2008CA2376919C Arylthiazolidinedione and aryloxazolidinedione derivatives
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2332814C Combination therapy for treatment of refractory depression
11/04/2008CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
11/04/2008CA2324260C Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
11/04/2008CA2310458C Piperidine derivatives
11/04/2008CA2301943C Antimicrobial compounds
11/04/2008CA2282893C Heat stable antacid and antigas suspensions
11/04/2008CA2261805C Promotion of wound healing by chemically-modified tetracyclines
11/04/2008CA2255521C Compositions for treatment of burns
11/04/2008CA2229183C Endothelin antagonist
11/04/2008CA2136870C Anti-aids immunomodulation complex
11/02/2008CA2587064A1 Antimicrobial gel for skin
1 ... 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 ... 7860